Merck 2014 Annual Report Download - page 245

Download and view the complete annual report

Please find page 245 of the 2014 Merck annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 271

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • 178
  • 179
  • 180
  • 181
  • 182
  • 183
  • 184
  • 185
  • 186
  • 187
  • 188
  • 189
  • 190
  • 191
  • 192
  • 193
  • 194
  • 195
  • 196
  • 197
  • 198
  • 199
  • 200
  • 201
  • 202
  • 203
  • 204
  • 205
  • 206
  • 207
  • 208
  • 209
  • 210
  • 211
  • 212
  • 213
  • 214
  • 215
  • 216
  • 217
  • 218
  • 219
  • 220
  • 221
  • 222
  • 223
  • 224
  • 225
  • 226
  • 227
  • 228
  • 229
  • 230
  • 231
  • 232
  • 233
  • 234
  • 235
  • 236
  • 237
  • 238
  • 239
  • 240
  • 241
  • 242
  • 243
  • 244
  • 245
  • 246
  • 247
  • 248
  • 249
  • 250
  • 251
  • 252
  • 253
  • 254
  • 255
  • 256
  • 257
  • 258
  • 259
  • 260
  • 261
  • 262
  • 263
  • 264
  • 265
  • 266
  • 267
  • 268
  • 269
  • 270
  • 271

240 CONSOLIDATED FINANCIAL STATEMENTS → Notes to the Group accounts
Net gains and losses on financial instruments mainly include
measurement results from currency translation, fair value adjust-
ments, impairments and reversals of impairments as well as the
recognition of premiums and discounts. Dividends and interest
are
not recognized in the net gains and losses on financial instru-
ments, except for dividends and interest in the category “held for
trading”. The category “held
for trading” only includes derivatives
not in a hedging relationship.
The net gains and losses on financial instruments by category
on the reporting date were as follows:
Net gains or losses
€ million
2014 Interest Impairments
Reversals of
impairment
Fair value
adjustments
Disposal gains / losses
Financial instrument of the category
Held for trading – 90.8
Held to maturity 1.4
Loans and receivables 18.2 – 41.9 41.8
Available-for-sale 10.0 – 4.4 0.2
Other liabilities –141.4
Net gains or losses
€ million
2013 Interest Impairments
Reversals of
impairment
Fair value
adjustments
Disposal gains / losses
Financial instrument of the category
Held for trading 131.7
Held to maturity 2.5
Loans and receivables 10.3 – 47.2 42.1
Available-for-sale 15.1 – 4.1 1.6
Other liabilities –163.3
In 2014, foreign exchange gains of €53.3 million resulting from
receivables and payables in operating business, their economic
hedging, as well as hedging of forecast transactions in operating
business were recorded (2013: gains of €26.0 million). Foreign
exchange losses of €– 13.0 million resulting from financial bal-
ance sheet items, their economic hedging as well as fair value
fluctuations of option contracts to hedge forecast transactions
were recorded (2013: losses of €– 4.3 million).
The fair value of financial assets and liabilities is based on the
official market prices and market values quoted on the balance
sheet date (Level 1 assets and liabilities) as well as mathematical
calculation models with inputs observable in the market on the
balance sheet date (Level 2 assets and liabilities). Level 1 assets
comprise stocks and bonds and are classified as “available-for-
sale”, Level 1 liabilities comprise issued bonds and are classified as
“other liabilities”. Level 2 assets and liabilities are primarily liabil-
ities to banks classified as “other liabilities”, interest-bearing secu-
rities classified as “available-for-sale” as well as derivatives with
and without hedging relationships. The fair value of interest-bear-
ing securities is determined by discounting future cash flows using
market interest rates. The fair value measurement of forward ex-
change contracts and currency options uses spot and forward rates
as well as foreign exchange volatilities applying recognized math-
ematical principles. The fair value of interest rate swaps is deter-
mined with standard market valuation models using interest rate
curves available in the market.